Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Serum Chromogranin A in metastatic prostate cancer patients (CROSBI ID 92472)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Tarle, Marko Serum Chromogranin A in metastatic prostate cancer patients // Anticancer Research, 16 (1999), 6; 5663-5666-x

Podaci o odgovornosti

Tarle, Marko

engleski

Serum Chromogranin A in metastatic prostate cancer patients

We have reported serum chromogranin A and total PSA values in responders and nonresponders to both hormonal therapy and chemohormonal treatment using BPH subjects as controls... Insome nonresponders to Estracyt normal total PSA value together with F/TPSA well bellow 20 indicated contribution of an anaplastic tumor... In accordance with these preliminary data we advocate the CgA serotest assessment in candidates for hormonal therapy as well as during follow-up of pharmacological treatment.

prostate cancer; metastases; chromogranin A; therapy

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

16 (6)

1999.

5663-5666-x

objavljeno

0250-7005

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost